Twitxy
Saved
@CharnessMichael's profile picture
View on X

Michael Charness

@CharnessMichael

@VABostonHC, @harvardmed, @BUMedicine, @BrighamWomens Neurologist/neuroscientist. Views my own
Joined April 2022
44 Following 112 Followers 50 Posts

Latest posts 5

Michael Charness @CharnessMichael
How long is airborne SARS-CoV-2 infectious after an infected person leaves the room? Our new preprint suggests nearly 5 hours. researchsquare.com/article/rs-385…
@PaulSaxMD @linseymarr @EricTopol (1/3)
www.researchsquare.com Evidence from Whole Genome Sequencing of Aerosol Transmission of SARS-CoV-2 almost Five Hours after... Experimental evidence suggests that SARS-CoV-2 remains viable within aerosols with a half-life of approximately 1-3 hours, though changes in aerosol microenvironment may shorten viability to minutes....
Michael Charness @CharnessMichael
Happy to share our review of fetal alcohol spectrum disorders (FASD). FASD is a common cause of cognitive and behavioral disabilities and medical disorders in children and adults. nature.com/articles/s4157… @FASDUnited @GlobeKayLazar @benryanwrite @ReporterGoodman @NIAAAnews
www.nature.com Fetal alcohol spectrum disorders Nature Reviews Disease Primers - Fetal alcohol spectrum disorders (FASD) are characterized by neurodevelopmental impairment with or without facial dysmorphology, congenital anomalies and poor...
Michael Charness @CharnessMichael
Genetically identical SARS-CoV-2 RNA fragments in aerosols of all sizes obtained from a nurses station and human samples during a nosocomial outbreak. jamanetwork.com/journals/jaman… @PaulSaxMD @tony_breu @linseymarr @GlobeKayLazar
jamanetwork.com SARS-CoV-2 RNA in Aerosols During a Hospital Ward Outbreak This cohort study uses air samplers placed in hospital ward nurses stations and break rooms to detect aerosol-borne SARS-CoV-2 RNA during a nosocomial outbreak.
Michael Charness @CharnessMichael
#paxlovidrebound
-Updated our Paxlovid rebound preprint, which now includes 10 cases.
-Two cases of transmission during rebound, including one while presymptomatic on Day 12
researchsquare.com/article/rs-158…
@PaulSaxMD @michaelmina_lab @AshishKJha46
www.researchsquare.com Rapid Relapse of Symptomatic Omicron SARS-CoV-2 Infection Following Early Suppression with Nirmat... We describe relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir (NM/R) in 10 non-immunocompromised patients aged 31 to 71-years-old. Most patients improved rapidly...